Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires6d agoneutral
Cantor Fitzgerald Adjusts Price Target on Eli Lilly to $1,600 From $1,440MT Newswires6d agoneutral
Berenberg Adjusts Price Target on Eli Lilly and Company to $1,570 From $1,400Insider Monkey52d agoneutral
Eli Lilly (LLY) Gets a Big Price Target Boost, Analysts See 20% UpsideBarrons.com54d agobullish
Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to BuyGuruFocus.com58d agobearish
Morgan Stanley Downgrades Novo Nordisk to Sell on Lilly CompetitionGuruFocus.com58d agobearish
Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent CliffBarrons.com73d agobearish
Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren’t the ReasonThe Wall Street Journal73d agobearish
Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth ConcernsInsider Monkey149d agobullish
Goldman Sachs Maintains a Buy Rating on Eli Lilly (LLY), Cites Encouraging Obesity Treatment PipelinePharmaceutical Technology171d agobullish
Eli Lilly maintains M&A streak with $202m Engage Bio buyoutInsider Monkey177d agoneutral
Analyst Raises Eli Lilly (LLY) Price Target by $52 Following Q1 Report24/7 Wall St.187d agoneutral
Barclays Hikes Eli Lilly Price Target to $1,400: Tirzepatide Momentum Steals the Show24/7 Wall St.188d agoneutral
Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?